Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Diabetes

  Free Subscription


Articles published in Ophthalmology

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    May 2019
  1. FRANK RN
    Anti-Vascular Endothelial Growth Factor Injections for Diabetic Retinopathy: Continued Progress, More Questions.
    Ophthalmology. 2019;126:721-722.
    PubMed     Text format    


    April 2019
  2. WYKOFF CC, Shah C, Dhoot D, Coleman HR, et al
    Longitudinal Retinal Perfusion Status in Eyes with Diabetic Macular Edema Receiving Intravitreal Aflibercept or Laser in VISTA study.
    Ophthalmology. 2019 Apr 1. pii: S0161-6420(18)33320.
    PubMed     Text format     Abstract available


    March 2019
  3. SAHNI J, Patel SS, Dugel PU, Khanani AM, et al
    Simultaneous Inhibition of Angiopoietin-2 and VEGF-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial.
    Ophthalmology. 2019 Mar 21. pii: S0161-6420(18)33358.
    PubMed     Text format     Abstract available


  4. SCHACHAT AP
    If There Is Loss to Follow Up, Poor Outcomes May Be More Common after Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Retinopathy.
    Ophthalmology. 2019;126:414.
    PubMed     Text format    


    November 2018
  5. SAYRES R, Taly A, Rahimy E, Blumer K, et al
    Using a deep learning algorithm and integrated gradients explanation to assist grading for diabetic retinopathy.
    Ophthalmology. 2018 Nov 28. pii: S0161-6420(18)31575.
    PubMed     Text format     Abstract available


  6. SUN JK, Wang PW, Taylor S, Haskova Z, et al
    Durability of Diabetic Retinopathy Improvement with As-Needed Ranibizumab: Open-label Extension of RIDE and RISE Studies.
    Ophthalmology. 2018 Nov 9. pii: S0161-6420(18)30817.
    PubMed     Text format     Abstract available


  7. DU S, Chen S
    Re: Jampol et al.: Plasma vascular endothelial growth factor concentrations after intravitreous anti-vascular endothelial growth factor therapy for diabetic macular edema (Ophthalmology. 2018;7:1054-1063).
    Ophthalmology. 2018;125:e81-e82.
    PubMed     Text format    


    October 2018
  8. MALONEY MH, Schilz SR, Herrin J, Sangaralingham LR, et al
    Risk of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice.
    Ophthalmology. 2018 Oct 4. pii: S0161-6420(18)30063.
    PubMed     Text format     Abstract available


    September 2018
  9. SRIVASTAV K, Baskaran P
    Re: Zur et al.: OCT biomarkers as functional outcome predictors in diabetic macular edema treated with dexamethasone implant (Ophthalmology. 2018;125:267-275).
    Ophthalmology. 2018;125:e61.
    PubMed     Text format    


    August 2018
  10. NAKASHIMA H, Iwama Y, Tanioka K, Emi K, et al
    Paracentral Acute Middle Maculopathy following Vitrectomy for Proliferative Diabetic Retinopathy: Incidence, Risk Factors, and Clinical Characteristics.
    Ophthalmology. 2018 Aug 17. pii: S0161-6420(18)30905.
    PubMed     Text format     Abstract available


  11. SUN JK, Glassman AR, Beaulieu WT, Stockdale CR, et al
    Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy.
    Ophthalmology. 2018 Aug 7. pii: S0161-6420(18)31489.
    PubMed     Text format     Abstract available


  12. OBEID A, Su D, Patel SN, Uhr JH, et al
    Outcomes of Eyes Lost to Follow-Up with Proliferative Diabetic Retinopathy that received Panretinal Photocoagulation vs Intravitreal Anti-Vascular Endothelial Growth Factor.
    Ophthalmology. 2018 Aug 2. pii: S0161-6420(18)31079.
    PubMed     Text format     Abstract available


    July 2018
  13. BRESSLER SB, Beaulieu WT, Glassman AR, Gross JG, et al
    Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes.
    Ophthalmology. 2018 Jul 3. pii: S0161-6420(18)30577.
    PubMed     Text format     Abstract available


    May 2018
  14. KLEIN R, Lee KE, Danforth L, Tsai MY, et al
    The Relationship of Retinal Vessel Geometric Characteristics to the Incidence and Progression of Diabetic Retinopathy.
    Ophthalmology. 2018 May 17. pii: S0161-6420(18)30530.
    PubMed     Text format     Abstract available


  15. WONG TY, Sun J, Kawasaki R, Ruamviboonsuk P, et al
    Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings.
    Ophthalmology. 2018 May 15. pii: S0161-6420(17)33523.
    PubMed     Text format     Abstract available


  16. REDDY RK, Pieramici DJ, Gune S, Ghanekar A, et al
    Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE.
    Ophthalmology. 2018 May 8. pii: S0161-6420(17)33607.
    PubMed     Text format     Abstract available


  17. PAYNE JF, Clark WL, Bruce BB, Wykoff CC, et al
    Retinopathy Regression with Treat and Extend Ranibizumab for Diabetic Macular Edema.
    Ophthalmology. 2018 May 2. pii: S0161-6420(18)30678.
    PubMed     Text format    


    March 2018
  18. LIN J, Chang JS, Yannuzzi NA, Smiddy WE, et al
    Cost Evaluation of Early Vitrectomy versus Panretinal Photocoagulation and Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.
    Ophthalmology. 2018 Mar 29. pii: S0161-6420(18)30040.
    PubMed     Text format     Abstract available


  19. OBEID A, Gao X, Ali FS, Talcott KE, et al
    Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy after Panretinal Photocoagulation or Intravitreal Anti-VEGF Injections.
    Ophthalmology. 2018 Mar 29. pii: S0161-6420(17)33569.
    PubMed     Text format     Abstract available


  20. YANNUZZI NA, Sridhar J, Chang JS, Lin J, et al
    Cost Evaluation of Laser versus Intravitreal Aflibercept for Proliferative Diabetic Retinopathy.
    Ophthalmology. 2018 Mar 20. pii: S0161-6420(18)30299.
    PubMed     Text format    


  21. GUPTA P, Liang Gan AT, Kidd Man RE, Fenwick EK, et al
    Impact of Incidence and Progression of Diabetic Retinopathy on Vision-Specific Functioning.
    Ophthalmology. 2018 Mar 20. pii: S0161-6420(17)32967.
    PubMed     Text format     Abstract available


  22. JAMPOL LM, Glassman AR, Liu D, Aiello LP, et al
    Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.
    Ophthalmology. 2018 Mar 7. pii: S0161-6420(17)32232.
    PubMed     Text format     Abstract available


  23. KRAUSE J, Gulshan V, Rahimy E, Karth P, et al
    Grader Variability and the Importance of Reference Standards for Evaluating Machine Learning Models for Diabetic Retinopathy.
    Ophthalmology. 2018 Mar 2. pii: S0161-6420(17)32698.
    PubMed     Text format     Abstract available


    February 2018
  24. LIU L, Tham YC
    Re: Keel et al.: The prevalence of diabetic retinopathy in Australian adults with self-reported diabetes: The National Eye Health Survey (Ophthalmology. 2017;124:977-984).
    Ophthalmology. 2018;125:e13-e14.
    PubMed     Text format    


    January 2018
  25. FIGUEIRA J, Fletcher E, Massin P, Silva R, et al
    Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
    Ophthalmology. 2018 Jan 27. pii: S0161-6420(17)32188.
    PubMed     Text format     Abstract available


  26. BROWN DM, Ou WC, Wong TP, Kim RY, et al
    Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial.
    Ophthalmology. 2018 Jan 11. pii: S0161-6420(17)31641.
    PubMed     Text format     Abstract available


  27. GRZYBOWSKI A, Kanclerz P
    Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: result of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785).
    Ophthalmology. 2018;125:e8-e9.
    PubMed     Text format    


  28. JONNA G, Kim SJ
    Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785).
    Ophthalmology. 2018;125:e4.
    PubMed     Text format    


  29. MODJTAHEDI BS, Fong DS
    Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785).
    Ophthalmology. 2018;125:e10-e11.
    PubMed     Text format    


    December 2017
  30. TAN GS, Gan A, Sabanayagam C, Tham YC, et al
    Ethnic Differences in the Prevalence and Risk Factors of Diabetic Retinopathy: The Singapore Epidemiology of Eye Diseases Study.
    Ophthalmology. 2017 Dec 4. pii: S0161-6420(17)31893.
    PubMed     Text format     Abstract available


  31. THOMAS M, Rao RC, Johnson MW, Paulus YM, et al
    Re: Bressler et al.: Factors associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab (Ophthalmology. 2017;124:431-439).
    Ophthalmology. 2017;124:e87-e88.
    PubMed     Text format    


    September 2017
  32. ZUR D, Iglicki M, Busch C, Invernizzi A, et al
    Optical Coherence Tomography Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
    Ophthalmology. 2017 Sep 18. pii: S0161-6420(17)32014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: